Interpretation of agonist affinity estimations: the question of distributed receptor states - PubMed (original) (raw)
Comparative Study
. 1990 Jun 22;240(1299):503-18.
doi: 10.1098/rspb.1990.0051.
Affiliations
- PMID: 1974062
- DOI: 10.1098/rspb.1990.0051
Comparative Study
Interpretation of agonist affinity estimations: the question of distributed receptor states
J W Black et al. Proc R Soc Lond B Biol Sci. 1990.
Abstract
In the receptor-transducer model of pharmacological agonism, rejection of the traditional assumption that receptor molecules are in vast excess of transducer molecules permits the receptors to become distributed among unbound, bound and complexed states. Under these conditions, agonist affinities are liable to be overestimated when the method of irreversible receptor antagonism is used. Graphical tests have been developed to detect distribution, and these were applied to experimental data from the interaction between 5-HT and phenoxybenzamine on aortic tissue. Significant receptor distribution was not detected by the method. However, in the model it was assumed that there was a linear relation between the concentration of ternary complex and pharmacological effect. If this relation was replaced with a saturable one the effect of receptor distribution would be masked. The implications for pharmacologists and medicinal chemists are discussed.
Similar articles
- An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. 1985.
Black JW, Leff P, Shankley NP, Wood J. Black JW, et al. Br J Pharmacol. 2010 Jul;160 Suppl 1(Suppl 1):S54-64. doi: 10.1111/j.1476-5381.2010.00855.x. Br J Pharmacol. 2010. PMID: 20590656 Free PMC article. No abstract available. - Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J, Venter DP, Brink CB. Bodenstein J, et al. J Pharmacol Exp Ther. 2005 Aug;314(2):891-905. doi: 10.1124/jpet.105.083568. Epub 2005 Apr 27. J Pharmacol Exp Ther. 2005. PMID: 15857948 - An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
Black JW, Leff P, Shankley NP, Wood J. Black JW, et al. Br J Pharmacol. 1985 Feb;84(2):561-71. doi: 10.1111/j.1476-5381.1985.tb12941.x. Br J Pharmacol. 1985. PMID: 3978322 Free PMC article. - Differential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta.
Wiener HL, Thalody GP. Wiener HL, et al. J Pharmacol Exp Ther. 1993 Nov;267(2):828-37. J Pharmacol Exp Ther. 1993. PMID: 7902436 - Characterization of the alpha-adrenergic effect of some 5-HT1A agonists.
Hong E, Castillo C, Ibarra M, Villalobos R. Hong E, et al. Proc West Pharmacol Soc. 1993;36:13-5. Proc West Pharmacol Soc. 1993. PMID: 8397417 No abstract available.
Cited by
- The mass action equation in pharmacology.
Kenakin T. Kenakin T. Br J Clin Pharmacol. 2016 Jan;81(1):41-51. doi: 10.1111/bcp.12810. Epub 2015 Dec 21. Br J Clin Pharmacol. 2016. PMID: 26506455 Free PMC article. Review. - 2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist.
Hull RA, Shankley NP, Harper EA, Gerkowitch VP, Black JW. Hull RA, et al. Br J Pharmacol. 1993 Mar;108(3):734-40. doi: 10.1111/j.1476-5381.1993.tb12870.x. Br J Pharmacol. 1993. PMID: 7682135 Free PMC article. - Determination of KA values by controlled receptor expression in Xenopus oocytes.
Murakoshi H, Nunoki K, Ishii K, Taira N. Murakoshi H, et al. Br J Pharmacol. 1995 Oct;116(3):2062-6. doi: 10.1111/j.1476-5381.1995.tb16412.x. Br J Pharmacol. 1995. PMID: 8640346 Free PMC article. - Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.
Strange PG. Strange PG. Br J Pharmacol. 2008 Apr;153(7):1353-63. doi: 10.1038/sj.bjp.0707672. Epub 2008 Jan 28. Br J Pharmacol. 2008. PMID: 18223670 Free PMC article. Review. - Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells.
Gardner B, Hall DA, Strange PG. Gardner B, et al. Br J Pharmacol. 1996 Jul;118(6):1544-50. doi: 10.1111/j.1476-5381.1996.tb15572.x. Br J Pharmacol. 1996. PMID: 8832084 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources